BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 6747777)

  • 1. The influence of clean room design on product contamination.
    Whyte W
    J Parenter Sci Technol; 1984; 38(3):103-8. PubMed ID: 6747777
    [No Abstract]   [Full Text] [Related]  

  • 2. Design control and validation of a facility for sterile clinical trial preparations.
    Staines L
    J Parenter Sci Technol; 1984; 38(3):109-14. PubMed ID: 6747778
    [No Abstract]   [Full Text] [Related]  

  • 3. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control.
    Elias WF
    Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322
    [No Abstract]   [Full Text] [Related]  

  • 4. A multicentred investigation of clean air requirements for terminally sterilized pharmaceuticals.
    Whyte W
    J Parenter Sci Technol; 1983; 37(4):138-44. PubMed ID: 6620047
    [No Abstract]   [Full Text] [Related]  

  • 5. Airborne microbial challenges of Blow/Fill/Seal equipment: a case study.
    Bradley A; Probert SP; Sinclair CS; Tallentire A
    J Parenter Sci Technol; 1991; 45(4):187-92. PubMed ID: 1770413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental microbial challenges to an aseptic Blow-Fill-Seal process--a practical study.
    Jones DJ; Topping P; Sharp J
    PDA J Pharm Sci Technol; 1995; 49(5):226-34. PubMed ID: 7489196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of laminar air flow and clean-room dress on contamination rates of intravenous admixtures.
    Brier KL; Latiolais CJ; Schneider PJ; Moore TD; Buesching WJ; Wentworth BC
    Am J Hosp Pharm; 1981 Aug; 38(8):1144-7. PubMed ID: 7270557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bacteriological quality of air in a ward for sterile pharmaceutical preparations].
    Caorsi P B; Sakurada Z A; Ulloa F MT; Pezzani V M; Latorre O P
    Rev Chilena Infectol; 2011 Feb; 28(1):14-8. PubMed ID: 21526280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Boundary and airlock design issues in aseptic facilities.
    Lorenz MR; Robinson JE
    J Parenter Sci Technol; 1991; 45(6):279-85. PubMed ID: 1802984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring.
    Raiman HL
    Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742
    [No Abstract]   [Full Text] [Related]  

  • 11. Request that the USP Committee of Revision reevaluate its position relative to the inclusion of clean room air and microbial limits in the U.S. Pharmacopeia (USP).
    Halperin JA
    J Parenter Sci Technol; 1991; 45(4):168. PubMed ID: 1770407
    [No Abstract]   [Full Text] [Related]  

  • 12. PDA comments: PIC draft recommendations on the inspection of isolator technology. Parenteral Drug Association.
    PDA J Pharm Sci Technol; 1999; 53(3):141-7. PubMed ID: 10754704
    [No Abstract]   [Full Text] [Related]  

  • 13. Reducing the risk of contamination of sterile parenteral products via ready-to-use closure components.
    Curry W; Conway S; Goodfield C; Miller K; Mueller RL; Polini E
    AAPS PharmSciTech; 2010 Dec; 11(4):1572-9. PubMed ID: 21057904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 15. Particles in intravenous solutions: a review.
    Thomas WH; Lee YK
    N Z Med J; 1974 Aug; 80(522):170-8. PubMed ID: 4608302
    [No Abstract]   [Full Text] [Related]  

  • 16. Aseptic work under various hygienic conditions.
    Aslund B; Olson OT; Sandell E
    Acta Pharm Suec; 1977; 14(5-6):517-24. PubMed ID: 596167
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contamination control. 1. The sterile working bench].
    Wahlström L
    Sven Farm Tidskr; 1966 Nov; 70(31):729-33. PubMed ID: 5979053
    [No Abstract]   [Full Text] [Related]  

  • 18. Sterility-testing program for antibiotics and other intravenous admixtures.
    Choy FN; Lamy PP; Burkhart VD; Tenney JH
    Am J Hosp Pharm; 1982 Mar; 39(3):452-6. PubMed ID: 7041640
    [No Abstract]   [Full Text] [Related]  

  • 19. Aerobiological model for assessing microbial contamination.
    Lipscomb B; Avis KE
    J Parenter Drug Assoc; 1979; 33(1):3-16. PubMed ID: 253025
    [No Abstract]   [Full Text] [Related]  

  • 20. Computer-assisted evaluation of microbiological environmental control data.
    Russell MP; Purdie RN; Goldsmith JA; Phillips I
    J Parenter Sci Technol; 1984; 38(3):98-102. PubMed ID: 6747782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.